Autolus Therapeutics plc (6A3A) — Strategic Asset Allocation Index
Autolus Therapeutics plc (6A3A) has a Strategic Asset Allocation Index of 39.7% as of June 2023. Strategic assets (PP&E of €91.11 Million plus long-term investments of €-) total €91.11 Million, measured against net assets of €229.34 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Autolus Therapeutics plc balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Autolus Therapeutics plc Strategic Asset Allocation Index (2017–2022)
This chart shows how Autolus Therapeutics plc's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of June 2023, the index stands at 39.7%, representing strategic assets of €91.11 Million against net assets of €229.34 Million EUR. For live market cap and overall valuation, see how much is Autolus Therapeutics plc worth.
Annual Strategic Asset Allocation Index for Autolus Therapeutics plc (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Autolus Therapeutics plc from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Autolus Therapeutics plc net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 19.6% | €58.42 Million | €58.42 Million | €- | €298.67 Million | ▲ +2.9 pp |
| 2021 | 16.7% | €52.32 Million | €52.32 Million | €- | €313.32 Million | ▼ -26.0 pp |
| 2020 | 42.7% | €89.68 Million | €89.68 Million | €- | €210.03 Million | ▲ +22.5 pp |
| 2019 | 20.2% | €51.57 Million | €51.57 Million | €- | €254.84 Million | ▲ +12.4 pp |
| 2018 | 7.8% | €19.97 Million | €19.97 Million | €- | €255.47 Million | ▲ +3.5 pp |
| 2017 | 4.3% | €6.18 Million | €6.18 Million | €- | €142.60 Million | — |